Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.
about
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsE3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colonCyclic AMP-mediated chloride secretion is induced by prostaglandin F2alpha in human isolated colonUpregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2.Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects.Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in miceAntineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies.Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy.Cyclic AMP-dependent Cl- secretion induced by thromboxane A2 in isolated human colon.Platelet-activating factor regulates chloride transport in colonic epithelial cell monolayers.Nitric oxide-induced Cl- secretion in isolated rat colon is mediated by the release of thromboxane A2.Phospholipid fatty acid composition and diamine oxidase activity of intestinal mucosa from rats treated with irinotecan hydrochloride (CPT-11) under vegetable oil-enriched diets: comparison between perilla oil and corn oil.CPT-11-Induced Delayed Diarrhea Develops via Reduced Aquaporin-3 Expression in the Colon.Effect of genistein, a natural soy isoflavone, on the pharmacokinetics and intestinal toxicity of irinotecan hydrochloride in rats
P2860
Q28079705-0D27D619-92AB-40F9-812B-B4C2DB088BB7Q28580312-696CEFA8-AB2A-4A01-AB2B-801170094FE3Q33569548-B480774D-EF4D-4F12-8CEA-D1F24737E146Q34652269-8D9AE5BD-D051-4102-ABAA-B327618A25FBQ36619832-A3A1D094-B440-4A28-B7CA-01B7A643E559Q36623755-4AD9E6DE-0BA3-4727-940E-BDD1DC8BE91AQ37448363-35E63410-F890-44F1-BF59-CC966B718F07Q37731433-0EFFD683-64EC-485B-B06E-46130D7590C2Q37827656-5AA5F851-D90C-4619-8ECC-20BA9F355AC5Q40478735-9C100E1F-CC6E-4C5F-821A-7712A8AB027AQ44083751-2975CFAE-B724-44DF-BAF6-D6CEB31CA4F2Q44104150-272A3583-26D7-4529-A8DA-C64B8EEF3C71Q46976059-CD5E7199-F9B9-4179-A215-4D35C4365D13Q47724378-0CFEEE71-0CC6-4441-A10C-E1AED9393CDBQ57113952-75C48493-2DB1-4EAD-87D2-0ED701E8C351
P2860
Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Thromboxane A2, released by th ...... cretion in isolated rat colon.
@en
Thromboxane A2, released by th ...... cretion in isolated rat colon.
@nl
type
label
Thromboxane A2, released by th ...... cretion in isolated rat colon.
@en
Thromboxane A2, released by th ...... cretion in isolated rat colon.
@nl
prefLabel
Thromboxane A2, released by th ...... cretion in isolated rat colon.
@en
Thromboxane A2, released by th ...... cretion in isolated rat colon.
@nl
P2093
P2860
P1476
Thromboxane A2, released by th ...... cretion in isolated rat colon.
@en
P2093
B Kakinoki
N Takeguchi
P2860
P304
P356
10.1111/J.1469-7793.1997.133BC.X
P407
P478
505 ( Pt 1)
P577
1997-11-01T00:00:00Z